LeMaitre Vascular Announces Changes to Its Executive Management Team

BURLINGTON, Mass., April 10 /PRNewswire-FirstCall/ -- LeMaitre Vascular,
Inc. (Nasdaq: LMAT) today announced the departure of Kevin D. Kelly, Senior
Vice President, North American Sales, to pursue other business opportunities
and the appointment of Robert V. Linden to Vice President, North American
Sales.
Mr. Linden has approximately six years North American sales experience
with LeMaitre Vascular. He joined LeMaitre Vascular in July 2002 as a Sales
Representative and has served in positions of increasing responsibility within
the North American organization. Since January 2008, he has served as
Director of Sales for the Eastern United States and Canada, supervising three
of the company's five North American sales regions. From 2005 through 2007,
Mr. Linden served as Regional Sales Manager. Prior to LeMaitre Vascular, Mr.
Linden served as a sales representative at several medical device companies,
including Vasca, Inc., Atrium Medical Corporation, Active Medical, Inc., and
DePuy Orthopedics, Inc. Mr. Linden holds a B.A. in Marketing from The
Pennsylvania State University.
LeMaitre Vascular Chairman and Chief Executive Officer George W. LeMaitre
stated, "We want to thank Kevin Kelly for his contributions and we wish him
the best. We are thrilled to promote Rob Linden to the position of Vice
President, North American Sales. I have watched Rob succeed at our company in
positions of increasing responsibility over the past six years. We believe he
will build on this experience to provide effective leadership for our North
American sales organization."
About LeMaitre Vascular
LeMaitre Vascular develops, manufactures, and markets medical devices for
the treatment of peripheral vascular disease. The company's principal
executive offices are located at 63 Second Avenue, Burlington, Massachusetts
01803.
Certain statements set forth above that are not clearly historical in
nature are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Although the company believes that
such statements are based on reasonable assumptions within the bounds of its
knowledge, these forward-looking statements are neither promises nor
guarantees. The forward-looking statements made in this release are made only
as of the date hereof, and the company disclaims any intention or
responsibility for updating predictions or expectations contained in this
release.
SOURCE LeMaitre Vascular, Inc.

Aaron Grossman, Investor Relations of LeMaitre Vascular, Inc.,
+1-781-221-2266